Ziv Ben Ari - Concepedia

Author

Ziv Ben Ari

Also Known As

Ben Ari, Z., Shiffman, Mitchell L., Z Ari, Z Ben Ari, Z. B. Ari, Z. Ben Ari, Z.B. Ari, Z.Ben Ari, Ziv BEN ARI, Ziv Ben Ari

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

Tel Aviv University Sheba Medical Center Rabin Medical Center Goethe University Frankfurt Bar-Ilan University

About

Ziv Ben Ari is an author at Tel Aviv University specializing in medicine, hepatology, and hepatitis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	1.6K
2	Health Sciences	1	1	52
3	Allergy	1	1	41
4	Epidemiology	1	1	14
5	Gastroenterology	1	1	20

Ziv Ben Ari

Publications

Citations

H-Index

Page 1

	Year	Citations
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial Zobair M. Younossi, Vlad Ratziu, Rohit Loomba, The Lancet Interim AnalysisMetabolic Associated SteatohepatitisHepatologyPlacebo-controlled Phase 3Nonalcoholic Fatty Liver Disease	2019	1.2K
Grazoprevir–Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection Stefan Zeuzem, Reem Ghalib, K. Rajender Reddy, Annals of Internal Medicine	2015	514
Metabolic syndrome in liver transplant recipients Ido Laish, Marius Braun, Eytan Mor, Liver Transplantation	2010	257
Effectiveness of Ledipasvir-Sofosbuvir Combination in Patients With Hepatitis C Virus Infection and Factors Associated With Sustained Virologic Response Norah A. Terrault, Stefan Zeuzem, Adrian M. Di Bisceglie, Gastroenterology Factors AssociatedHepatologyHepatitis CViral HepatitisAntiviral Drug Development	2016	221
A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver disease Manuel Romero‐Gómez, Eric Lawitz, R. Ravi Shankar, Journal of Hepatology	2023	163
Lusutrombopag for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Invasive Procedures (L‐PLUS 2) Markus Peck‐Radosavljevic, Krzysztof Simon, A. Iacobellis, Hepatology	2019	141
Reduced Hepatic Injury in Toll-Like Receptor 4–Deficient Mice Following D-Galactosamine/Lipopolysaccharide-Induced Fulminant Hepatic Failure Ziv Ben Ari, Orna Avlas, Orit Pappo, Cellular Physiology and Biochemistry	2012	83
Azathioprine-induced myelosuppression due to thiopurinemethyltransferase deficiency in a patient with autoimmune hepatitis Ziv Ben Ari, Atul Mehta, Lynne Lennard, Journal of Hepatology HepatologyAutoimmune DiseaseAzathioprine-induced MyelosuppressionHematologyImmunology	1995	63
A Comparison of Transjugular and Plugged-Percutaneous Liver Biopsy in Patients with Contraindications to Ordinary Percutaneous Liver Biopsy and an “In-House” Protocol for Selecting the Procedure of Choice Eli Atar, Ziv Ben Ari, Gil N. Bachar, CardioVascular and Interventional Radiology HepatologyPlugged-percutaneous Liver BiopsySurgical PathologyHistopathologyDiagnosis	2009	52
A third dose of the BNT162b2 mRNA vaccine significantly improves immune responses among liver transplant recipients Yana Davidov, Victoria Indenbaum, Keren Tsaraf, Journal of Hepatology VaccinationTransplantationVaccine DevelopmentAllergyLiver Transplant Recipients	2022	41

Page 1